Yale Cardiovascular Medicine Grand Rounds: "Predicting and Preventing Sudden Cardiac Death in Patients Without Systolic Dysfunction"
Dr. Albert's research focuses on epidemiology, risk stratification and prevention of sudden cardiac death and atrial fibrillation in large prospective cohort designs and in multi-center clinical studies, most notably seminal contributions regarding the contribution of diet, lifestyle and genetics to the burden of heart rhythm disorders. Dr. Albert is Principal Investigator on two ongoing R01s funded by the National Institutes of Health. She is currently testing the effect of omega-3 fatty acids on atrial fibrillation and sudden cardiac death incidence in a large-scale primary prevention randomized trial being performed in 25,000 individuals. Dr. Albert is also leading a 5,800-patient multicenter clinical study that aims to identify those at increased risk for sudden cardiac death by employing combinations of clinical, lifestyle, biomarker, genetic and imaging data.
- To convey current challenges in the field of sudden cardiac death prevention
- To discuss potential future solutions that may improve sudden death prevention in patients without systolic dysfunction
- To demonstrate the importance of considering competing risk in sudden cardiac death risk stratification
Smidt Heart Institute at Cedars-SinaiChristine M. Albert, MD, MPHLee and Harold Kapelovitz Distinguished Chair in Cardiology